Forte Biosciences (FBRX) Other Non-Current Assets (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 7912.0% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 7912.0% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 1393.48% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.0 million, down from $2.1 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for FBRX reached as high as $2.1 million in Q4 2025 and fell as low as $12000.0 in Q1 2023.
• Historically, Other Non-Current Assets has averaged $529058.8 across 5 years, with a median of $192000.0 in 2024.
• Across the five-year window, Other Non-Current Assets sank 93.89% in 2025 and jumped 7912.0% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $13000.0 in 2022, then jumped by 4084.62% to $544000.0 in 2023, then sank by 74.63% to $138000.0 in 2024, then surged by 1393.48% to $2.1 million in 2025, then retreated by 2.81% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.0 million in Q1 2026, $2.1 million in Q4 2025, and $1.5 million in Q3 2025.